1. Home
  2. OXBR vs CTXR Comparison

OXBR vs CTXR Comparison

Compare OXBR & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXBR
  • CTXR
  • Stock Information
  • Founded
  • OXBR 2013
  • CTXR 2007
  • Country
  • OXBR Cayman Islands
  • CTXR United States
  • Employees
  • OXBR N/A
  • CTXR N/A
  • Industry
  • OXBR Property-Casualty Insurers
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • OXBR Finance
  • CTXR Health Care
  • Exchange
  • OXBR Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • OXBR 12.7M
  • CTXR 14.6M
  • IPO Year
  • OXBR 2014
  • CTXR N/A
  • Fundamental
  • Price
  • OXBR $1.75
  • CTXR $1.53
  • Analyst Decision
  • OXBR Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • OXBR 1
  • CTXR 3
  • Target Price
  • OXBR $5.00
  • CTXR $53.00
  • AVG Volume (30 Days)
  • OXBR 96.7K
  • CTXR 6.7M
  • Earning Date
  • OXBR 08-07-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • OXBR N/A
  • CTXR N/A
  • EPS Growth
  • OXBR N/A
  • CTXR N/A
  • EPS
  • OXBR N/A
  • CTXR N/A
  • Revenue
  • OXBR $1,363,000.00
  • CTXR N/A
  • Revenue This Year
  • OXBR $497.99
  • CTXR N/A
  • Revenue Next Year
  • OXBR $42.14
  • CTXR N/A
  • P/E Ratio
  • OXBR N/A
  • CTXR N/A
  • Revenue Growth
  • OXBR N/A
  • CTXR N/A
  • 52 Week Low
  • OXBR $1.27
  • CTXR $0.65
  • 52 Week High
  • OXBR $5.81
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • OXBR 57.92
  • CTXR 68.44
  • Support Level
  • OXBR $1.65
  • CTXR $0.76
  • Resistance Level
  • OXBR $1.94
  • CTXR $1.45
  • Average True Range (ATR)
  • OXBR 0.18
  • CTXR 0.31
  • MACD
  • OXBR 0.03
  • CTXR 0.06
  • Stochastic Oscillator
  • OXBR 90.40
  • CTXR 47.63

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: